These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 3315505)

  • 1. Intracellular autoantigens: diagnostic fingerprints but aetiological dilemmas.
    Tan EM; Reimer G; Sullivan K
    Ciba Found Symp; 1987; 129():25-42. PubMed ID: 3315505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antinuclear antibodies: diagnostic markers and clues to the basis of systemic autoimmunity.
    Tan EM
    Pediatr Infect Dis J; 1988 May; 7(5 Suppl):S3-9. PubMed ID: 2456507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoantibodies in connective tissue diseases: clinical significance and analysis of target autoantigens.
    Mimori T
    Intern Med; 1999 Jul; 38(7):523-32. PubMed ID: 10435356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antinuclear antibodies (ANAs): diagnostically specific immune markers and clues toward the understanding of systemic autoimmunity.
    Tan EM; Chan EK; Sullivan KF; Rubin RL
    Clin Immunol Immunopathol; 1988 May; 47(2):121-41. PubMed ID: 3280190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoantibodies to nonhistone nuclear antigens and their clinical significance.
    Nakamura RM; Tan EM
    Hum Pathol; 1983 May; 14(5):392-400. PubMed ID: 6341205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Update on autoantibodies to intracellular antigens in systemic rheumatic diseases.
    Nakamura RM; Tan EM
    Clin Lab Med; 1992 Mar; 12(1):1-23. PubMed ID: 1563236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recently characterised autoantibodies and their clinical significance.
    Sturgess A
    Aust N Z J Med; 1992 Jun; 22(3):279-89. PubMed ID: 1497555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antinuclear autoantibodies in systemic diseases].
    Butov IuS
    Vestn Dermatol Venerol; 1980 Nov; (11):17-22. PubMed ID: 7003977
    [No Abstract]   [Full Text] [Related]  

  • 9. [Spectrum of antinuclear and anti-cytoplasmic antibodies in dermatomyositis and polymyositis overlap syndromes].
    Meurer M; Hausmann-Martinez-Pardo G; Braun-Falco O
    Hautarzt; 1989 Oct; 40(10):623-9. PubMed ID: 2482267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antinuclear and anticytoplasmic antibodies. Concepts and misconceptions.
    Sontheimer RD; Deng JS; Gilliam JN
    J Am Acad Dermatol; 1983 Sep; 9(3):335-43. PubMed ID: 6415131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Scl-86, a marker antigen for diffuse scleroderma.
    van Venrooij WJ; Stapel SO; Houben H; Habets WJ; Kallenberg CG; Penner E; van de Putte LB
    J Clin Invest; 1985 Mar; 75(3):1053-60. PubMed ID: 3980727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of recombinant proteins in the diagnosis of autoimmune connective tissue diseases.
    Galperin C; Coppel RL; Gershwin ME
    Int Arch Allergy Immunol; 1996 Dec; 111(4):337-47. PubMed ID: 8957106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoantibodies to nucleolar antigens in systemic scleroderma: clinical correlations.
    Błaszczyk M; Jarzabek-Chorzelska M; Jabłońska S; Chorzelski T; Kołacińska-Strasz Z; Beutner EH; Kumar V
    Br J Dermatol; 1990 Oct; 123(4):421-30. PubMed ID: 2128868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiribonuclease H2 antibodies are an immune biomarker for systemic lupus erythematosus.
    Nozawa K; Doe K; Uomori K; Sekigawa I; Takasaki Y; Yamaji K; Tamura N
    Autoimmunity; 2017 Jun; 50(4):241-246. PubMed ID: 28553742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Shared and distinctive characteristics of systemic autoimmune disorders].
    Kiss E; Dankó K; Süto G; Zeher M
    Orv Hetil; 2007 Apr; 148 Suppl 1():44-51. PubMed ID: 17430794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison between 3 diagnostic criteria for mixed connective tissue disease. Study of 593 patients.
    Alarcón-Segovia D; Cardiel MH
    J Rheumatol; 1989 Mar; 16(3):328-34. PubMed ID: 2724251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C1D is a major autoantibody target in patients with the polymyositis-scleroderma overlap syndrome.
    Schilders G; Egberts WV; Raijmakers R; Pruijn GJ
    Arthritis Rheum; 2007 Jul; 56(7):2449-54. PubMed ID: 17599775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effective use of autoantibody tests in the diagnosis of systemic autoimmune disease.
    Lyons R; Narain S; Nichols C; Satoh M; Reeves WH
    Ann N Y Acad Sci; 2005 Jun; 1050():217-28. PubMed ID: 16014537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunologic tests: Anti-polymyositis-scleroderma (PM-Scl) antibody].
    Takasaki Y
    Nihon Rinsho; 2005 Jul; 63 Suppl 7():502-4. PubMed ID: 16111314
    [No Abstract]   [Full Text] [Related]  

  • 20. [Occurrence of autoantibodies and the clinical course of mixed connective tissue disease, systemic scleroderma, dermatomyositis, polymyositis and Sjögren's syndrome].
    Prokop J; Zietkiewicz E; Słomski R
    Przegl Dermatol; 1986; 73(4):327-31. PubMed ID: 3333867
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.